MSD and Google Cloud have formed a multi-year partnership, investing up to $1bn, to advance agentic AI enterprise transformation.
Pharmaceutical Technology on MSN
MSD-backed Ray locks in $125m to back eye drug pipeline
The MSD and Novo Holdings-backed Series B will shed light on the potential of Ray’s vision restoration treatment pipeline.
MSD has agreed a deal with Google Cloud that will put the tech giant's AI tools in the hands of its 75,000 employees ...
Merck & Co (MSD) and Eisai’s combination therapies failed to meet the dual primary endpoints of progression-free survival ...
Pharmaceutical Technology on MSN
FDA approves MSD’s once-daily HIV combo Idvynso
GlobalData analysts forecast a blockbuster future for Idvynso, though they note it is unlikely it will displace market ...
Merck & Co (MSD) has received the European Commission (EC) approval for Enflonsia (clesrovimab), indicated to prevent ...
A combination regimen for kidney cancer treatment based on MSD's Welireg has failed a phase 3 trial, denting the company's ...
Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up Last month, we challenged the two elected officials who make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results